Delivery Order SPE2DB22D3501-SPE2DB25FWF15

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,258.32 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set aside and was awarded on June 26, 2025, with a completion date of June 27,...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, valued at $2,375.10, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $2,127.35, is a firm fixed-price delivery order with an ultimate completion date of January 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S medical patches, with a ceiling value of $2,439.52. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,933.12. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on April 26, 2024. The contract is a Delivery Order with a Firm Fixed Price of $1,340.75 and a period of performance ending on April 29, 2024. It was awarded without any set-aside designation, indicating...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 2, 2022, with a ceiling value of $16,733.69 and a completion date of May 3, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,944.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 7, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,269.48 and is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp. The IDC, valued up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award is for the procurement of XULANE 150-35 MCG/DAY PATCH 3S medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,853.05 and has an ultimate completion date of February 19, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FWF15
    Delivery Order

This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,164.77 and is a firm fixed-price delivery order with an ultimate completion date of June 30, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and was awarded on June 27, 2025. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026.

Generated 9/26/25, 9:59 AM